SCRS Resource Guide Network

Sites, Sponsors, CROs: Discover the solutions your clinical research teams need with SCRS.

Selected Products (21) 

  • Veeva SiteVault
    Veeva Systems | Veeva SiteVault

    Veeva SiteVault Free is a 21 CFR Part 11 and HIPAA compliant eRegulatory application used by more than 4,000 clinical research sites across over 75 countries. SiteVault Free replaces paper binders and manual processes and connects sites to over 400 sponsors using Veeva Clinical applications. 

    Veeva SiteVault
  • RealTime-TEXT
    RealTime Software Solutions, LLC

    Take patient engagement to a whole new level with RealTime-TEXT. Improving patient retention while reducing no show rates will keep your research studies on track for success. Automated appointment reminders boost retention rates and enhance the patient experience.

  • RealTime-PAY
    RealTime Software Solutions, LLC

    Streamline your stipend payment process while providing your patients with a convenient payment card that’s easy to use.

  • RealTime-eDOCS
    RealTime Software Solutions, LLC

    Our industry-leading eRegulatory system, RealTime-eDOCS, is streamlining the way sites, sponsors and CROs manage regulatory documents electronically. Sites are now easily managing all of their study records while maintaining inspection readiness during the entire process.

  • RealTime-eSOURCE
    RealTime Software Solutions, LLC

    RealTime is a proven leader of advanced research information systems. RealTime-eSOURCE is no exception as it was built and tested by research site professionals. Additionally, our eSOURCE has more features, greater scalability, better support, and all at an affordable price.

  • RealTime-CTMS
    RealTime Software Solutions, LLC

    RealTime-CTMS is designed to provide quick and easy access to study or subject information utilizing simple and intuitive navigation. In most cases, needed information is only a few clicks away. RealTime-CTMS will guide you from study start-up to study close-out, and everything in between.

  • ConneX

    ConneX, the most personalized clinical trial travel solution, is designed specifically to meet the retention goals of global clinical trials. From simply setting up a ride, to full-service travel arrangements, ConneX provides peace of mind for patients, families, caregivers, sites, and sponsors.

    Greenphire understands the complexities of clinical trial travel, whether by protocol, therapeutic area or region. ConneX can be configured to meet the diverse needs of each participant, eliminating logistical restrictions or limitations.

  • eClinicalGPS

    eClinicalGPS automates, streamlines, and accelerates global site payments, increasing overall site satisfaction. It also provides you with the cash flow transparency you need for more effective clinical trial forecasting, planning, tracking and quantitative assessment.

  • ClinCard

    ClinCard allows you to reimburse and notify your patients instantly. It simplifies the clinical trial payment process and maximizes overall participant satisfaction, giving you more time to focus on your research. Using ClinCard instead of cash, money orders, rewards and other reimbursement methods has been proven to reduce patient drop out.

    Research sites that use ClinCard see a cost and time savings within months of completing their implementation. ClinCard reduces administrative burden, eliminates errors and rework that come with manual processes and gives research team access to real-time, clean and accurate financial data for comprehensive reporting and visibility.

  • Site Experience
    Clinical Ink

    Intuitive eSource for Optimal Site Efficiency

    An effective eSource solution must be intuitive enough to effectively make clinical research easier. From the beginning, Clinical Ink’s SureSource® platform was designed for optimal site efficiency. Developed and tested with actual site users, SureSource is the only eSource solution designed to actually reduce site workload.

    Clinical Ink
  • Risk-Based Monitoring
    Clinical Ink

    eSource Enabled Risk-Based Monitoring

    In the face of increasing clinical trial costs, complexity and regulations, drug makers are under increasing pressure to save money while executing more efficient clinical trials. In an effort to enhance subject protection and clinical trial data quality, the Food and Drug Administration (FDA) issued final industry guidance in August 2013, “Oversight of Clinical Investigations – A Risk-Based Approach to Monitoring”.

    Clinical Ink
  • eSource Data Capture
    Clinical Ink

    In an effort to streamline and modernize clinical investigations, the U.S. Food and Drug Administration (FDA) in September 2013 issued final guidance on Electronic Source Data in Clinical Investigations. In this guidance, the agency promotes capturing source data in electronic form to assist in ensuring the reliability, quality, integrity and traceability of data from electronic source to electronic regulatory submission.

    Clinical Ink
  • Late Phase Clinical Development
    Clinical Ink

    Well-conducted Phase II clinical trials provide the data required to determine if there’s a case to be made for progressing a drug candidate into Phase III trials. However, Phase II success rates are lower than at any other phase of development. These larger late phase studies present unique challenges and even greater opportunities for the use of eSource to reduce costs and timelines.

    Clinical Ink
  • Early Phase Clinical Development
    Clinical Ink

    The goal of early-phase clinical development – Phase I through IIa – is to test for the safety and efficacy of a drug candidate. In any disease state, conducting successful early phase trials is a key component of ushering a novel therapy through clinical development. Clinical Ink’s integrated SureSource® platform streamlines clinical development – from start to submit — to dramatically reduce R&D costs and project timelines while improving data quality and patient safety.

    Clinical Ink
  • SMART- Technology Solution

    BRANY's SMART system allows study sites to develop study budgets and conduct cost analyses utilizing pricing information stored within the database. Users can also manage and store regulatory documents.

    This easy-to-use, online solution allows investigators and research staff to:

    • Manage trial initiation, funding, and sponsor relations
    • Assist in contract and budget development
    • Handle accounting from start to finish, including holdback reconciliation
    • Track investigators, subjects, and trial progress

    The web-based software-as-a-service (SaaS) also allows clients to track completed subject visits and study procedures, revenue, and accounts receivable..

  • Smart-Start-60: Guaranteed Site Start-up Within 60 Days

    • BRANY understands the importance of high quality, human subject research, and offers customized services to expedite the initiation of trials at any of our affiliate sites.
    • The 60-day program includes: budget development, contract negotiations, completion of regulatory documents (including ICF modifications), and IRB submission and review.
    • All of this, plus the convenience of a single-point of contact for rapid response and focused client support.
    • According to Kimberly Irvine, Executive Vice President, Operations for BRANY: “Smart-Start-60 is an essential tool for sponsors and CROs to keep trials on schedule. Every day a study does not get up and running, is another day of missed milestones with significant budget impact.”
    • On the occasion of the launch of Smart-Start-60, BRANY is offering new and returning clients an introductory rate.

  • Research Subject Payment Options

    BRANY has partnered with Greenphire (www.greenphire.com) to offer our sites options for subject payments. Greenphire provides innovative electronic payment and communication technology products and services to the clinical trials industry. Its team takes a service-driven approach to customizing, designing, implementing and supporting each ClinCard program. As a BRANY site, you will receive a 5% discount on the setup costs

  • Education and Training

    We offer several educational programs through the BRANY Institute for Research Education. Our instructors include experts in the fields of research compliance and IRB standards. Options available both at your site and online

    A choice of locations:

    • Courses are offered at the BRANY offices in Lake Success, NY. We will also present any BRANY course at your facility.
    • Who should take these classes? These classes are a must for any clinical research professional including principal investigators, research coordinators, research pharmacists, regulatory coordinators, and data managers who need to be familiar with the federal regulations, ethical guidelines, and processes involved in the conduct of human subject research.

    Programs are offered in the following areas:

    • Conducting Clinical Trials
    • IRB
    • Monitoring
    • Finance / Budgeting

    Selected BRANY Education programs are approved by the...

  • Clinical Trial Identification

    • We have relationships with leading pharmaceutical, biotech and medical device companies and CROs. We provide a connection to those companies, and help you forge long-term relationships for ongoing business development opportunities.
    • For physicians and hospitals looking to build out clinical research activities, BRANY can help identify clinical research opportunities that match your research interest and staff expertise.

  • Devana Solutions
    Devana Solutions

    We provide technology solutions to align the best Research Sites with Sponsors and CROs to reduce drug development costs and cure disease.

    Devana Solutions
  • Firecrest
    ICON Clinical Research

    The ultimate investigator training and support system

    As clinical trials become more complex, an increasing burden is being placed on investigators who have to deal with the frequent protocol amendments, more complex procedures and an ever expanding case report form. Ineffective training, inadequate communications and poor data capture methods contribute to poor trial performances which inevitably result in delayed recruitment, frequent non-compliances with protocols and ultimately, delayed study close-out and market approval.

    ICON Clinical Research